Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition.

Our data mining of the NCI-60 readily picked talazoparib, the most potent PARP trapping inhibitor [ 7 ] as showing a highly significant correlation between cancer cell killing and SLFN11 transcript levels (Figure 1A ).

also in 132,142 other papers